Journals / Türkiye Diyabet ve Obezite Dergisi / 2017 / Cilt: 1 - Sayı: 3

Relationship of Potential Inflammatory Markers Namely Neutrophile Lymphocyte Ratio and Platelet Lymphocyte Ratio With the Severity of Obstructive Sleep Apnea

Enflamatuar Belirteç Olarak Nötrofil Lenfosit Oranı, Platelet Lenfosit Oranı gibi Hematolojik Parametrelerin Tıkayıcı Uyku Apne Sendromunun Şiddeti ile İlişkisinin Değerlendirilmesi

Pages
125–131
Publication Date
2017-12-03
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There is a debate over putative relationship between NLR, PLR, and OSAS.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The aim of the present study is to evaluate hematological parameters in patients with obstructive sleep apnea syndrome (OSAS).Material and Methods: Patients underwent a polysomnographic (PSG) test at our sleep laboratory was retrospectively reviewed.
📊
Key Findings & Data:Two hundred and ten OSAS patients with an apnea-hypopnea index (AHI) of more than five events and 57 controls with an AHI of less than four events were included.
💡
Conclusion & Impact:There is a debate over putative relationship between NLR, PLR, and OSAS.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Tıkayıcı uyku apne sendromu · OSAS · Nötrofil lenfosit oranı

Abstract

Aim: The aim of the present study is to evaluate hematological parameters in patients with obstructive sleep apnea syndrome (OSAS).Material and Methods: Patients underwent a polysomnographic (PSG) test at our sleep laboratory was retrospectively reviewed. Patients with cancer, cardiovascular disease, hematologic disorders, infectious diseases and rheumatologically disorders, renal or hepatic insufficiency were excluded from the study. Two hundred and ten OSAS patients with an apnea-hypopnea index (AHI) of more than five events and 57 controls with an AHI of less than four events were included. Study population was divided into four groups depending on the AHI as: mild OSAS (AHI= 5-15), moderate OSAS (AHI=15-30), severe OSAS (AHI>30), and the control (AHI<5). Hematologic parameters were measured and compared.Results: Platelet lymphocyte ratio was significantly lower in patients with OSAS compared to the control (p = 0.050). Neutrophil lymphocyte ratio between OSAS and the control was not different (p = 0.947). Serum triglyceride level and mean platelet volume were significantly higher in patients with OSAS (p < 0.0001; p = 0.043). Platelet distribution width was significantly higher in severe OSAS group compared to control, mild and moderate OSAS subgroups (0.014).Conclusion: No relationship was found between OSAS and NLR. There is a debate over putative relationship between NLR, PLR, and OSAS.

Özet

Amaç: Bu çalışmanın amacı tıkayıcı uyku apnesi (OSAS) olan hastalarda hematolojik parametrelerin değerlendirilmesidir.Gereç ve Yöntemler: Bu araştırmada uyku laboratuvarında Polisomnografi testi yapılan hastalar geriye dönük olarak değerlendirilmiştir. Kanser, kardiyovasküler hastalık, hematolojik bozukluk, enfeksiyon hastalıkları, romatolojik hastalıklar, renal ve hepatik yetmezlik olan hastalar çalışmaya alınmamıştır. Çalışmaya apne-hipopne endeksi 5 olaydan fazla olan 210 hasta ve 57 AHI 5 den az olan kontrol olarak alınmıştır. Araştırma grubu polisomnografideki AHI skorlarına göre 4 gruba ayrılmıştır: hafif OSAS (AHI= 5-15), orta OSAS (AHI=15- 30), ciddi OSAS (AHI> 30), ve kontrol (AHI<5). Hematolojik parametreler değerlendirilmiş ve karşılaştırılmıştır.Bulgular: Trombosit lenfosit oranı OSAS hastalarında kontrol grubuna göre anlamlı düşük saptanmıştır. (p = 0.050). OSAS ve kontrol grupları arasında nötrofil lenfosit oranı yönünden istatistiksel olarak anlamlı farklılık izlenmemiştir (p = 0.947). Serum trigliserid ve ortalama trombosit hacmi OSAS hastalarında anlamlı yüksek izlenmiştir (p < 0.0001; p = 0.043). Trombosit dağılım hacmi ciddi OSAS grubunda kontrol grubuna ve diğer OSAS alt gruplarına göre anlamlı yüksek saptanmıştır. (p = 0.014).Sonuç: OSAS ve NLR arasında herhangi bir ilişki izlenmemiştir. NLR, PLR, ve OSAS arasındaki olası ilişki üzerine hâlâ araştırmaların sonuçları tartışmalıdır.

🔖

Cite This Article

DİKBAŞ, O., ERTEN, N., KÜÇÜKER, F., AKŞEHİRLİ, Ö. Y. (2017). Relationship of Potential Inflammatory Markers Namely Neutrophile Lymphocyte Ratio and Platelet Lymphocyte Ratio With the Severity of Obstructive Sleep Apnea. Türkiye Diyabet ve Obezite Dergisi, Cilt: 1 - Sayı: 3, 125–131. https://ajindex.com/articles/707725

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Gharibeh T, Mehra R. Obstructive sleep apnea syndrome: natural history, diagnosis, and emerging treatment options. Nature and science of sleep. 2010;2:233-55
  2. Azagra-Calero E, Espinar-Escalona E, Barrera-Mora JM, Llamas-Carreras JM, Solano-Reina E. Obstructive sleep apnea syndrome (OSAS). Review of the literature. Medicina oral, patologia oral y cirugia bucal. 2012;17(6):e925-9
  3. Maspero C, Giannini L, Galbiati G, Rosso G, Farronato G. Obstructive sleep apnea syndrome: a literature review. Minerva stomatologica. 2015;64(2):97-109
  4. Munoz R, Duran-Cantolla J, Martinez-Vila E, Gallego J, Rubio R, Aizpuru F, et al. Severe sleep apnea and risk of ischemic stroke in the elderly. Stroke; a journal of cerebral circulation. 2006;37(9):2317-21
  5. Partinen M. Epidemiology of obstructive sleep apnea syndrome. Current opinion in pulmonary medicine. 1995;1(6):482-7
  6. Botros N, Concato J, Mohsenin V, Selim B, Doctor K, Yaggi HK. Obstructive sleep apnea as a risk factor for type 2 diabetes. The American journal of medicine. 2009;122(12):1122-7
  7. Chen L, Pei JH, Chen HM. Effects of continuous positive airway pressure treatment on glycaemic control and insulin sensitivity in patients with obstructive sleep apnoea and type 2 diabetes: a meta-analysis. Archives of medical science: AMS. 2014;10(4):637-42
  8. Destors M, Tamisier R, Baguet JP, Levy P, Pepin JL. [Cardiovascular morbidity associated with obstructive sleep apnea syndrome]. Revue des maladies respiratoires. 2014;31(4):375-85
  9. Redline S, Yenokyan G, Gottlieb DJ, Shahar E, O’Connor GT, Resnick HE, et al. Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. American journal of respiratory and critical care medicine. 2010;182(2):269-77
  10. Ryan S, Taylor CT, McNicholas WT. Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Postgraduate medical journal. 2009;85(1010):693-8
  11. Zamarron C, Valdes Cuadrado L, Alvarez-Sala R. Pathophysiologic mechanisms of cardiovascular disease in obstructive sleep apnea syndrome. Pulmonary medicine. 2013;2013:521087
  12. Castro-Anon O, Perez de Llano LA, De la Fuente Sanchez S, Golpe R, Mendez Marote L, Castro-Castro J, et al. Obesityhypoventilation syndrome: increased risk of death over sleep apnea syndrome. PloS one. 2015;10(2):e0117808
  13. Ucar ZZ, Cirak AK, Olcay S, Uysal H, Demir AU, Ozacar R. Association of duration of sleep and cardiovascular and metaboli